Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) is 19.68% higher on its value in year-to-date trading and has touched a low of $0.31 and a high of $4.00 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CYCC stock was last observed hovering at around $0.46 in the last trading session, with the day’s loss setting it -0.01%.
Currently trading at $0.45, the stock is 22.97% and 4.16% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.61 million and changing -2.17% at the moment leaves the stock -65.74% off its SMA200. CYCC registered -80.21% loss for a year compared to 6-month loss of -71.34%. The firm has a 50-day simple moving average (SMA 50) of $0.4448 and a 200-day simple moving average (SMA200) of $1.32255.
The stock witnessed a 12.50% gain in the last 1 month and extending the period to 3 months gives it a -50.73%, and is 26.94% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 35.12% over the week and 15.49% over the month.
Profit margin for the company is -18217.57%. Distance from 52-week low is 45.11% and -88.75% from its 52-week high.
.
Cyclacel Pharmaceuticals Inc (CYCC) Top Institutional Holders
19.0 institutions hold shares in Cyclacel Pharmaceuticals Inc (CYCC), with institutional investors hold 18.94% of the company’s shares. The shares outstanding are 6.29M, and float is at 6.20M with Short Float at 1.07%. Institutions hold 18.03% of the Float.
Cyclacel Pharmaceuticals Inc (CYCC) Insider Activity
#####
